Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II study.

L. Miglietta,D. Amoroso,M Bruzzone,Granetto C,E Catsafados,Serafina Mammoliti,Domenico Guarneri,Francesco Pedullà,G Foglia,Nicola Ragni,M.C. Martini,Fulvio Brema,G.F. Addamo,L. Moraglio,Gisella Pastorino,Francesco Boccardo

Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II study.

1997

L. Miglietta
D. Amoroso
M Bruzzone
Granetto C
E Catsafados
Serafina Mammoliti
Domenico Guarneri
Francesco Pedullà
G Foglia
Nicola Ragni
M.C. Martini
Fulvio Brema
G.F. Addamo
L. Moraglio
Gisella Pastorino
Francesco Boccardo

Background: While ovarian cancer is one of the most sensitive cancers to cytotoxic drugs, with objective response rates of 60-80% routinely being reported in previously untreated pa

Keywords:

Phases of clinical research
Pathology
Ovarian cancer
Oncology
Cancer
Ifosfamide
Cisplatin
Medicine
Paclitaxel
Gynecology
Nitrogen mustard
Chemotherapy
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations